Debanjana Chatterjee
Stock Analyst at JonesTrading
(4.93)
# 179
Out of 4,572 analysts
233
Total ratings
63.6%
Success rate
42.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HYFT MindWalk Holdings | Maintained: Buy | $5 | $1.36 | +267.65% | 2 | Jul 23, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $31 | $7.07 | +338.47% | 17 | Jul 21, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | $13 | $5.31 | +144.82% | 6 | Jul 15, 2026 | |
| ATHE Alterity Therapeutics | Maintained: Buy | $16 | $4.54 | +252.42% | 2 | Jul 8, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $10 | $3.08 | +224.68% | 21 | Jul 8, 2026 | |
| EYPT EyePoint | Maintained: Buy | $43 | $12.19 | +252.75% | 26 | Jul 6, 2026 | |
| TBPH Theravance Biopharma | Downgraded: Hold | $19 → $17 | $16.86 | +0.83% | 12 | Jun 29, 2026 | |
| SION Sionna Therapeutics | Reiterated: Buy | $63 | $45.70 | +37.86% | 8 | Jun 25, 2026 | |
| ABSI Absci | Rated: Buy | $11 → $13 | $7.56 | +71.96% | 18 | Jun 24, 2026 | |
| SYRE Spyre Therapeutics | Rated: Buy | $95 → $104 | $102.13 | +1.83% | 18 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $34.17 | +52.18% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.66 | +329.18% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $10.73 | +170.27% | 27 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.034 | - | 8 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.51 | +378.09% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.96 | +237.84% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $14.06 | +84.92% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $17.54 | +36.87% | 21 | May 6, 2026 |
MindWalk Holdings
Jul 23, 2026
Maintained: Buy
Price Target: $5
Current: $1.36
Upside: +267.65%
Sagimet Biosciences
Jul 21, 2026
Maintained: Buy
Price Target: $31
Current: $7.07
Upside: +338.47%
AbCellera Biologics
Jul 15, 2026
Maintained: Buy
Price Target: $13
Current: $5.31
Upside: +144.82%
Alterity Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $16
Current: $4.54
Upside: +252.42%
Opus Genetics
Jul 8, 2026
Maintained: Buy
Price Target: $10
Current: $3.08
Upside: +224.68%
EyePoint
Jul 6, 2026
Maintained: Buy
Price Target: $43
Current: $12.19
Upside: +252.75%
Theravance Biopharma
Jun 29, 2026
Downgraded: Hold
Price Target: $19 → $17
Current: $16.86
Upside: +0.83%
Sionna Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $63
Current: $45.70
Upside: +37.86%
Absci
Jun 24, 2026
Rated: Buy
Price Target: $11 → $13
Current: $7.56
Upside: +71.96%
Spyre Therapeutics
Jun 16, 2026
Rated: Buy
Price Target: $95 → $104
Current: $102.13
Upside: +1.83%
Jun 11, 2026
Maintained: Buy
Price Target: $52
Current: $34.17
Upside: +52.18%
May 27, 2026
Reiterated: Buy
Price Target: $20
Current: $4.66
Upside: +329.18%
May 27, 2026
Reiterated: Buy
Price Target: $29
Current: $10.73
Upside: +170.27%
May 22, 2026
Rated: Hold
Price Target: n/a
Current: $0.034
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $2.51
Upside: +378.09%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $2.96
Upside: +237.84%
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $14.06
Upside: +84.92%
May 6, 2026
Maintained: Buy
Price Target: $24
Current: $17.54
Upside: +36.87%